Deep Medicine Acquisition Corp.
DMAQ | NASDAQ
$2.96
-$5.43 (-64.72%)
At close: Jan 31, 2024, 04:00 PM ET
Market Data
Market Cap $12.9M
Enterprise Value $11.56M
Beta 0.02
Average Volume N/A
Shares Outstanding (Diluted) 1.21M
Shares Change YoY 67.98%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -74.3%
1Y CAGR (ann.) -71.3%
5Y CAGR (ann.) N/A
All-Time CAGR -42.6%
Valuation
PE Ratio -0.09
Forward PE N/A
PEG Ratio -0.00
Forward PEG -0.00
PS Ratio 0.63
Forward PS N/A
PB Ratio 6.26
P/FCF Ratio -10.78
P/Adj. FCF Ratio -10.84
P/OCF Ratio -1.44
EV/Sales 0.57
EV/EBIT N/A
EV/EBITDA 12.93
EV/FCF -9.66
Earnings Yield -1123.7%
FCF Yield -9.3%
Adj. FCF Yield -9.2%
Financial Health
Net Cash $1.33M
Total Debt $5.04M
Cash & Short-Term Investments $6.37M
Total Assets $18M
Current Ratio 0.84
Quick Ratio 0.74
Debt / Equity Ratio 2.45
Debt / EBITDA 5.63
Debt / FCF -4.21
OCF / Debt -0.49
Interest Coverage 2.22
Altman Z-Score -2.29
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 54.4%
Operating Profit Margin -21.9%
EBITDA Margin 4.4%
Net Profit Margin -60.7%
FCF Margin -5.9%
Adj. FCF Margin -5.8%
SBC / Revenue 0.0%
SBC Impact (per share) -0.6%
Returns
Return on Assets -68.6%
Return on Equity -292.1%
Return on Invested Capital -53.2%
Return on Capital Employed -128.6%
Return on Tangible Assets -68.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 509.3%
Revenue CAGR 5Y 63.1%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -91.5%
EPS CAGR 5Y -80.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y -4.0%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Sep 29, 2023
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-2.47M
Free Cash Flow $-1.2M
Adj. Free Cash Flow $-1.19M
FCF Per Share -$0.99
OCF Per Share -$2.05
OCF/S Ratio -12.1%
Income Statement
Revenue $20.36M
Gross Profit $11.07M
Operating Income $-4.45M
EBITDA $894.6K
Net Income $-12.35M
EPS (Diluted) -$33.26
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove DMAQ